ProKidney appoints Dr. Bruce Culleton as executive VP of clinical development and commercialization

Dr. Culleton brings over two decades of industry and academic experience in kidney health to ProKidney, a public biotech company that is working to advance its regenerative medicine therapy through multiple clinical trials.

Native American Community Clinic gets OK on mixed-use Minneapolis development

Minnesota State Fair gets a strong start — and a new record — for 2023 attendance

Bed Bath & Beyond adds more Minnesota stores to closure list

300-unit build-for-rent, 500-home single-family communities headed to Fort Worth

Busting myths about ICHRAs once and for all

PGA Tour players come to Greensboro with qualification for $56.6 million playoffs on the line

MillerCoors CEO calls Bud Light corn syrup ad a ‘gift’

Fortune favors the bold: How to exercise control when facing uncertainty

ProKidney appoints Dr. Bruce Culleton as executive VP of clinical development and commercialization

Previous Olive Tree Compounding Pharmacy breaks ground on Rio Rancho location

Next Exclusive: Forbici Modern Italian is coming to downtown St. Pete

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Sanford developer bets on apartment demand with VinFast, Toyota and Wolfspeed on the way

The List: Here are the area’s largest SBA borrowers & lenders

Jacksonville company among those building hundreds of homes in Texas community

Smithfield clears path for 2,000-home development

Denver housing market suffers dramatic swing in 2018

CEO says Inovio is ‘closer than ever’ to delivering first FDA-approved DNA medicine

MENU

FirstStar Group

More Stories

Small Deposits: Janney adds Wells Fargo wealth group; SEI names private banking head